The Valley Desk

NCT03346434 · Interventional trial

Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)

Overall registry status Completed

Phase 2 · Phase 3

Conditions Dermatitis, Atopic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov